Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.

Drug Resistance, Bacterial Clinical Trial

— R'EHPAD  

Official title:

Determination of the Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes in Franche-Comté (France).

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03248999
• Other study ID #: P/2017/315
• Status: Completed
• Phase: N/A
• Start date: November 20, 2017
• Est. completion date: June 26, 2018

Study information

• Verified date: March 2018
• Source: Centre Hospitalier Universitaire de Besancon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates individual and collective factors of ESBL and CRE carriage in nursing homes.

Description:

Epimiological data concerning ESBL an CRE, may differ between nursing home and hospital or community but poor data are available.

Multi-drug resistant bacteria carriage is associated with individual and collective factors wich have to be defined in nursing homes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 264
• Est. completion date: June 26, 2018
• Est. primary completion date: June 26, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• voluntary residents present in the institution on the study day

Exclusion Criteria:

• dement-wandering resident

• unlikely to cooperate

Related Conditions & MeSH terms

• Drug Resistance, Bacterial

Intervention

Diagnostic Test:
• rectal swab
stool samples by rectal swab

Locations

Country	Name	City	State
France	CHU Besançon	Besançon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ESBL and CRE carriage	number of residents colonized with a extented-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL) or carbapenem-resistant Enterobacteriaceae (CRE)	the day of the study
Secondary	patient and establishment factors associated with ESBL and CRE carriage with a questionnaire	evaluation of risk factors associated with ESBL and CRE carriage and disseminationwith a questionnaire.	the day of the study